These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

264 related items for PubMed ID: 15230855

  • 1. Longitudinal mapping of protective CD4+ T cell responses against HCV: analysis of fluctuating dominant and subdominant HLA-DR11 restricted epitopes.
    Harcourt GC, Lucas M, Sheridan I, Barnes E, Phillips R, Klenerman P.
    J Viral Hepat; 2004 Jul; 11(4):324-31. PubMed ID: 15230855
    [Abstract] [Full Text] [Related]

  • 2. Characterization of novel HLA-DR11-restricted HCV epitopes reveals both qualitative and quantitative differences in HCV-specific CD4+ T cell responses in chronically infected and non-viremic patients.
    Godkin A, Jeanguet N, Thursz M, Openshaw P, Thomas H.
    Eur J Immunol; 2001 May; 31(5):1438-46. PubMed ID: 11465100
    [Abstract] [Full Text] [Related]

  • 3. Minimal T-cell-stimulatory sequences and spectrum of HLA restriction of immunodominant CD4+ T-cell epitopes within hepatitis C virus NS3 and NS4 proteins.
    Gerlach JT, Ulsenheimer A, Grüner NH, Jung MC, Schraut W, Schirren CA, Heeg M, Scholz S, Witter K, Zahn R, Vogler A, Zachoval R, Pape GR, Diepolder HM.
    J Virol; 2005 Oct; 79(19):12425-33. PubMed ID: 16160170
    [Abstract] [Full Text] [Related]

  • 4. Genetic variability of hepatitis C virus non-structural protein 3 and virus-specific CD8+ response in patients with chronic hepatitis C.
    López-Labrador FX, He XS, Berenguer M, Cheung RC, González-Candelas F, Wright TL, Greenberg HB.
    J Med Virol; 2004 Apr; 72(4):575-85. PubMed ID: 14981760
    [Abstract] [Full Text] [Related]

  • 5. Mutations in immunodominant T cell epitopes derived from the nonstructural 3 protein of hepatitis C virus have the potential for generating escape variants that may have important consequences for T cell recognition.
    Wang H, Eckels DD.
    J Immunol; 1999 Apr 01; 162(7):4177-83. PubMed ID: 10201944
    [Abstract] [Full Text] [Related]

  • 6. Relation between viral fitness and immune escape within the hepatitis C virus protease.
    Söderholm J, Ahlén G, Kaul A, Frelin L, Alheim M, Barnfield C, Liljeström P, Weiland O, Milich DR, Bartenschlager R, Sällberg M.
    Gut; 2006 Feb 01; 55(2):266-74. PubMed ID: 16105887
    [Abstract] [Full Text] [Related]

  • 7. Cross-genotype-reactivity of the immunodominant HCV CD8 T-cell epitope NS3-1073.
    Fytili P, Dalekos GN, Schlaphoff V, Suneetha PV, Sarrazin C, Zauner W, Zachou K, Berg T, Manns MP, Klade CS, Cornberg M, Wedemeyer H.
    Vaccine; 2008 Jul 23; 26(31):3818-26. PubMed ID: 18582999
    [Abstract] [Full Text] [Related]

  • 8. Induction of potent and long-lasting CD4 and CD8 T-cell responses against hepatitis C virus by immunization with viral antigens plus poly(I:C) and anti-CD40.
    Zabaleta A, Arribillaga L, Llopiz D, Dotor J, Lasarte JJ, Prieto J, Borrás-Cuesta F, Esteban JI, Quer J, Vayreda F, Sarobe P.
    Antiviral Res; 2007 Apr 23; 74(1):25-35. PubMed ID: 17275104
    [Abstract] [Full Text] [Related]

  • 9. Positive selection of cytotoxic T lymphocyte escape variants during acute hepatitis C virus infection.
    Guglietta S, Garbuglia AR, Pacciani V, Scottà C, Perrone MP, Laurenti L, Spada E, Mele A, Capobianchi MR, Taliani G, Folgori A, Vitelli A, Ruggeri L, Nicosia A, Piccolella E, Del Porto P.
    Eur J Immunol; 2005 Sep 23; 35(9):2627-37. PubMed ID: 16114108
    [Abstract] [Full Text] [Related]

  • 10. Differential capacity of T cell priming in naive donors of promiscuous CD4+ T cell epitopes of HCV NS3 and Core proteins.
    Castelli FA, Leleu M, Pouvelle-Moratille S, Farci S, Zarour HM, Andrieu M, Auriault C, Ménez A, Georges B, Maillere B.
    Eur J Immunol; 2007 Jun 23; 37(6):1513-23. PubMed ID: 17492804
    [Abstract] [Full Text] [Related]

  • 11. Characterization of T-cell responses against immunodominant epitopes from hepatitis C virus E2 and NS4a proteins.
    Sarobe P, Lasarte JJ, García N, Civeira MP, Borrás-Cuesta F, Prieto J.
    J Viral Hepat; 2006 Jan 23; 13(1):47-55. PubMed ID: 16364082
    [Abstract] [Full Text] [Related]

  • 12. Hypervariable region 1 variants act as TCR antagonists for hepatitis C virus-specific CD4+ T cells.
    Frasca L, Del Porto P, Tuosto L, Marinari B, Scottà C, Carbonari M, Nicosia A, Piccolella E.
    J Immunol; 1999 Jul 15; 163(2):650-8. PubMed ID: 10395654
    [Abstract] [Full Text] [Related]

  • 13. Virus-specific T-cell responses associated with hepatitis C virus (HCV) persistence in the liver after apparent recovery from HCV infection.
    Quiroga JA, Llorente S, Castillo I, Rodríguez-Iñigo E, López-Alcorocho JM, Pardo M, Carreño V.
    J Med Virol; 2006 Sep 15; 78(9):1190-7. PubMed ID: 16847959
    [Abstract] [Full Text] [Related]

  • 14. Intrahepatic and circulating HLA class II-restricted, hepatitis C virus-specific T cells: functional characterization in patients with chronic hepatitis C.
    Penna A, Missale G, Lamonaca V, Pilli M, Mori C, Zanelli P, Cavalli A, Elia G, Ferrari C.
    Hepatology; 2002 May 15; 35(5):1225-36. PubMed ID: 11981773
    [Abstract] [Full Text] [Related]

  • 15. Dominant influence of an HLA-B27 restricted CD8+ T cell response in mediating HCV clearance and evolution.
    Neumann-Haefelin C, McKiernan S, Ward S, Viazov S, Spangenberg HC, Killinger T, Baumert TF, Nazarova N, Sheridan I, Pybus O, von Weizsäcker F, Roggendorf M, Kelleher D, Klenerman P, Blum HE, Thimme R.
    Hepatology; 2006 Mar 15; 43(3):563-72. PubMed ID: 16496339
    [Abstract] [Full Text] [Related]

  • 16. Novel CD4+ and CD8+ T-cell determinants within the NS3 protein in subjects with spontaneously resolved HCV infection.
    Wertheimer AM, Miner C, Lewinsohn DM, Sasaki AW, Kaufman E, Rosen HR.
    Hepatology; 2003 Mar 15; 37(3):577-89. PubMed ID: 12601356
    [Abstract] [Full Text] [Related]

  • 17. Vaccination with recombinant NY-ESO-1 protein elicits immunodominant HLA-DR52b-restricted CD4+ T cell responses with a conserved T cell receptor repertoire.
    Bioley G, Dousset C, Yeh A, Dupont B, Bhardwaj N, Mears G, Old LJ, Ayyoub M, Valmori D.
    Clin Cancer Res; 2009 Jul 01; 15(13):4467-74. PubMed ID: 19531622
    [Abstract] [Full Text] [Related]

  • 18. Genetic immunization and comprehensive screening approaches in HLA-A2 transgenic mice lead to the identification of three novel epitopes in hepatitis C virus NS3 antigen.
    Martin P, Parroche P, Chatel L, Barretto C, Beck A, Trépo C, Bain C, Lone YC, Inchauspé G, Fournillier A.
    J Med Virol; 2004 Nov 01; 74(3):397-405. PubMed ID: 15368525
    [Abstract] [Full Text] [Related]

  • 19. Mapping of immunodominant CD4+ T lymphocyte epitopes of hepatitis C virus antigens and their relevance during the course of chronic infection.
    Hoffmann RM, Diepolder HM, Zachoval R, Zwiebel FM, Jung MC, Scholz S, Nitschko H, Riethmüller G, Pape GR.
    Hepatology; 1995 Mar 01; 21(3):632-8. PubMed ID: 7875660
    [Abstract] [Full Text] [Related]

  • 20. Characterization of HCV-specific Patr class II restricted CD4+ T cell responses in an acutely infected chimpanzee.
    Woollard DJ, Grakoui A, Shoukry NH, Murthy KK, Campbell KJ, Walker CM.
    Hepatology; 2003 Nov 01; 38(5):1297-306. PubMed ID: 14578870
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.